Somru BioScience Revenue and Competitors
Estimated Revenue & Valuation
- Somru BioScience's estimated annual revenue is currently $5.1M per year.
- Somru BioScience's estimated revenue per employee is $155,000
Employee Data
- Somru BioScience has 33 Employees.
- Somru BioScience grew their employee count by -11% last year.
Somru BioScience's People
Name | Title | Email/Phone |
---|---|---|
1 | CEO | Reveal Email/Phone |
2 | Director Corporate Services | Reveal Email/Phone |
3 | Global Project Manager | Reveal Email/Phone |
4 | Principal Investigator | Reveal Email/Phone |
5 | Account Manager / Logistics Leader | Reveal Email/Phone |
Somru BioScience Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $19.7M | 127 | -5% | $132.7M | N/A |
#2 | $8.8M | 57 | -7% | $2M | N/A |
#3 | $12.9M | 83 | 5% | N/A | N/A |
#4 | $10.2M | 66 | 8% | N/A | N/A |
#5 | $101.6M | 468 | -11% | $94.5M | N/A |
#6 | $22.5M | 262 | 0% | $845.8M | N/A |
#7 | $9.8M | 34 | -68% | $494.1M | N/A |
#8 | $443.8M | 673 | 11% | $371.2M | N/A |
#9 | $27.6M | 178 | 19% | N/A | N/A |
#10 | $82M | 378 | 8% | $871.5M | N/A |
What Is Somru BioScience?
The rise of biosimilars has provided challenges and opportunities in equal measure for biotechnology, biopharmaceutical and bioanalytical contract research organizations (CROs). Somru BioScience has developed a portfolio of reagents, tools, solutions and a knowledge database that will enable companies to capitalize on biosimilar opportunities. We provide comprehensive expertise and solutions to reduce both the time and cost of your biosimilar development programs
keywords:N/AN/A
Total Funding
33
Number of Employees
$5.1M
Revenue (est)
-11%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $4.1M | 35 | N/A | N/A |
#2 | $4.1M | 35 | N/A | N/A |
#3 | $8.2M | 41 | 8% | N/A |
#4 | $6.7M | 43 | 139% | N/A |
#5 | $12.9M | 65 | 25% | N/A |